Discretionary DE40 Trading Strategy
Real capital • Live execution • Publicly verified performance
A discretionary trading strategy focused primarily on the German DAX (DE40), combining QM / IQM reversal setups with structured DCA execution. Occasional long-only exposure to Ethereum (ETH) may also be taken when predefined market conditions are met.
German DAX (DE40)
QM / IQM + Structured DCA
Fully discretionary and manual
Long & Short
Long only, occasional
Intraday & short-term swing
The primary execution model uses Quasimodo and Inverse Quasimodo reversal patterns confirmed by Break of Structure (BoS). Each trade is executed independently with predefined risk parameters, a fixed stop loss and a fixed take profit.
The secondary model builds positions through predefined technical entry levels when the original market analysis remains valid. Each additional position uses the same fixed trade size on the reference execution account. No Martingale or progressive position sizing is used.
Ethereum is a supplementary market rather than a permanent component of the strategy. Long positions may be opened only when predefined market conditions and setup criteria are met. ETH short positions are not used.
Every trade is executed manually. BlueCore ONE does not use Expert Advisors, automated execution systems or AI-based trading software.
Trading decisions are based on Price Action, Market Structure, Liquidity, Supply & Demand, Volatility and Higher Time Frame Analysis.
The market is monitored throughout the European trading session, with each position managed according to current market conditions.
Fixed stop loss, fixed take profit and a predefined 1:2.95 risk-to-reward structure on the reference execution framework.
Additional entries use equal position sizing rather than progressive sizing. Total exposure is controlled through predefined entry zones and exposure limits.
Position size does not increase simply because the market moves against an existing position.
Position sizing may differ between accounts and execution environments. Subscribers should select exposure appropriate to their own account size, risk tolerance and overall portfolio.
BlueCore ONE is executed using real capital on a live MetaTrader 5 account. Performance is tracked publicly through independent third-party platforms.
The strategy is executed on a live trading account using real capital. No backtests or simulated results are presented as live performance.
Trading history and performance statistics are publicly available through independent third-party platforms such as SignalStart and MQL5.
Investors retain control over their own trading accounts and capital. No client funds are transferred to or managed by BlueCore ONE.
BlueCore ONE may be followed through independent third-party platforms that support the strategy.
Follow the instructions provided by the selected platform to connect your own trading account.
You remain responsible for your own account, capital allocation and risk settings.
BlueCore ONE does not provide copy-trading infrastructure. Trade replication, where available, is performed through independent third-party platforms.
BlueCore ONE is available through selected third-party trading platforms. The subscription fee is currently $30 per month.
BlueCore ONE is currently executed on a private Tickmill Standard account.
Execution conditions can vary between brokers and accounts due to differences in spreads, execution speed, slippage, liquidity and margin requirements.
BlueCore ONE participates in the Tickmill affiliate program and may receive compensation if you register through our referral link.
BlueCore ONE publishes trading signals and strategy information for informational purposes only.
BlueCore ONE does not provide investment advice, portfolio management or financial advisory services, and does not accept or manage client funds.
Trading CFDs and financial indices involves substantial risk and may not be suitable for all investors. Past performance does not guarantee future results.
Periods of drawdown are a natural part of trading. Subscribers should understand the risks of leveraged trading and choose exposure appropriate to their individual financial circumstances and risk tolerance.